
Comparing Balloon-Based and Medication-Based Weight Loss
The weight loss landscape has changed dramatically. GLP-1 medications like Ozempic, Wegovy, and Zepbound have dominated headlines — but they come with ongoing costs, indefinite injections, and a troubling pattern of weight regain when patients stop. Now, the Allurion Balloon offers another option without injections. It is indicated to promote short-term limited weight loss in adults aged 22 to 65 with a BMI of 30 to 40 who have had at least one unsuccessful weight-loss attempt. In its FDA trial: 6.87% average total body weight loss at 48 weeks vs 3.09% with lifestyle therapy alone, with up to two balloons.
If you’re weighing the Allurion vs. Ozempic decision — or trying to decide between a balloon vs. semaglutide — this comprehensive guide from Dr. David G. Davtyan breaks down everything you need to know: cost, effectiveness, side effects, weight regain risks, and long-term value.
Have questions about which approach is right for you? Call 844-41-BALLOON to schedule a free consultation with Dr. Davtyan.
How the Allurion Balloon Works
The Allurion Balloon is an FDA-approved swallowable gastric balloon that needs no endoscopy for placement or removal. Rather than requiring surgery, endoscopy, or anesthesia, the Allurion system uses a remarkably simple approach:
- You swallow a small capsule with water during a routine office visit
- An X-ray confirms the capsule is in the stomach
- The balloon is filled with about 550 mL of fluid through the thin catheter
- The catheter is removed — and you’re done
The entire process takes approximately 15 minutes. There is no endoscopy, no anesthesia, and no sedation of any kind.
Once in place, the balloon occupies space in your stomach, helping you feel full faster and eat smaller portions. The Allurion program includes a Connected Scale, Health Tracker, a dedicated App, nutrition coaching, and lifestyle support — to support behavior change.
After about 16 weeks, the balloon deflates on its own and passes naturally. No removal procedure is needed. In the AUDACITY clinical study, patients had 6.87% average total body weight loss at 48 weeks vs 3.09% with lifestyle therapy alone, with up to two balloons. Follow-up ended at week 48, about 8 weeks after balloon #2 passed. The FDA summary has no data beyond 48 weeks.
Learn more about the Allurion Balloon at LapBandLA.
How GLP-1 Medications (Ozempic/Wegovy) Work
GLP-1 receptor agonists — including semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Zepbound and Mounjaro) — are injectable medications that mimic a hormone called glucagon-like peptide-1 (GLP-1). This hormone plays a role in regulating appetite and blood sugar.
Here’s how they work:
- Appetite suppression: GLP-1 medications slow gastric emptying (how quickly food leaves your stomach) and signal the brain to reduce hunger
- Weekly injections: Patients self-administer a subcutaneous injection once per week, typically in the abdomen, thigh, or upper arm
- Dose titration: Treatment starts at a low dose and is gradually increased over several weeks to months to reach the target therapeutic dose
- Ongoing use required: The medication must be taken continuously to maintain its effects. Stopping the medication removes the appetite-suppressing mechanism
GLP-1 medications have demonstrated significant weight loss in clinical trials. In the trials described in their FDA labels, semaglutide (Wegovy) produced average weight loss of about 15% of body weight at 68 weeks, and tirzepatide (Zepbound) about 15% to 21% at 72 weeks, depending on dose.
However, these results are dependent on continued medication use. The weight loss benefits last only as long as the patient keeps injecting.
Side-by-Side Comparison Table
This Allurion vs. Ozempic comparison table includes GLP-1 options so you can see how every major weight loss treatment stacks up:
| Feature | Allurion Balloon | Ozempic (Semaglutide) | Wegovy (Semaglutide) | Zepbound (Tirzepatide) |
|---|---|---|---|---|
| Treatment Type | Swallowable gastric balloon | GLP-1 injection (off-label for weight loss) | GLP-1 injection (FDA-approved for weight loss) | GLP-1/GIP injection (FDA-approved for weight loss) |
| Duration | ~16 weeks per balloon; up to two balloons over 10 months | Ongoing/indefinite | Ongoing/indefinite | Ongoing/indefinite |
| Avg. Total Body Weight Loss | 6.87% at 48 weeks, with up to two balloons (FDA summary) | Varies (off-label dose) | ~15% (FDA label, 68 wks) | ~15-21% by dose (FDA label, 72 wks) |
| Cost per Year | $4,000 | About $149-$449/month through self-pay programs; insurance varies | About $149-$449/month through self-pay programs; insurance varies | About $149-$449/month through self-pay programs; insurance varies |
| Common Side Effects | Nausea and vomiting nearly universal in the first days; can recur | Nausea, vomiting, diarrhea, constipation (ongoing) | Nausea, vomiting, diarrhea, constipation (ongoing) | Nausea, vomiting, diarrhea, constipation (ongoing) |
| FDA Status | FDA PMA Approved (Feb 2026) | FDA Approved (diabetes; off-label weight loss) | FDA Approved (weight management) | FDA Approved (weight management) |
| Requires Ongoing Use? | No, but the label program can include up to two balloons | Yes — weight regain when stopped | Yes — weight regain when stopped | Yes — weight regain when stopped |
| Administration | 15-min office visit | Weekly self-injection | Weekly self-injection | Weekly self-injection |
| Program Included | Yes (Scale, Tracker, App, coaching) | No (medication only) | No (medication only) | No (medication only) |

Cost: Program Fee vs. Ongoing Monthly Expense
One of the most significant differences between the Allurion Balloon and GLP-1 medications is the cost structure — and this is where the math tells a compelling story.
Allurion Balloon: Program Price
At LapBandLA, the complete Allurion Balloon program is $4,000. The price covers the items below. The FDA-labeled program can include up to two balloons over 10 months; ask what your quote covers.
- Free consultation with Dr. Davtyan
- Capsule placement visit
- X-ray confirmation
- Connected Scale
- Health Tracker
- App access
- Nutrition coaching
- Follow-up visits throughout the program
Ask what happens after the balloon passes and whether a second balloon is part of your plan.
GLP-1 Medications: Ongoing Monthly Cost
GLP-1 medications like Ozempic, Wegovy, and Zepbound cost about $149 to $449 a month through manufacturer self-pay programs in 2026, depending on the product and dose; insurance varies, and they require ongoing use to maintain results.
- Year 1: About $1,788 to $5,388 at those self-pay prices
- Year 2: About $3,576 to $10,776 (cumulative)
- Year 3: About $5,364 to $16,164 (cumulative)
Even with insurance coverage (which is not guaranteed and often requires prior authorization), copays, deductibles, and coverage gaps can add up significantly. Some patients face periods without coverage due to insurance changes, shortages, or policy updates.
The Bottom Line on Cost
Average weight loss in GLP-1 label trials was greater; the trials are not directly comparable.
Weight Regain: What Happens When You Stop?
This may be the most important question in the gastric balloon vs. GLP-1 debate: What happens to your weight loss when treatment ends?
GLP-1 Medications: The Regain Problem
Multiple studies have shown a troubling pattern with GLP-1 medications. When patients discontinue semaglutide or tirzepatide, research suggests that up to two-thirds of the lost weight may be regained within one year of stopping treatment.
This happens because GLP-1 medications work by suppressing appetite chemically. When the drug is removed, the appetite suppression disappears. If the patient has not fundamentally changed their eating habits and lifestyle during treatment, the weight returns.
This creates a difficult cycle: patients feel pressure to stay on expensive medication indefinitely, face weight regain if they stop, and may struggle with insurance coverage changes or medication shortages that interrupt treatment.
Allurion Balloon: Building Habits That Last
The Allurion program takes a fundamentally different approach. While the balloon is in place for approximately 16 weeks, patients simultaneously work with nutrition coaches, track their progress with the Connected Scale and Health Tracker, and use the Allurion App to build sustainable habits.
The balloon serves as a powerful catalyst — reducing appetite mechanically while the patient learns new eating patterns, portion awareness, and lifestyle behaviors. When the balloon passes, those habits have to continue, and weight can return.
In the FDA trial, average weight loss was 7.38% at week 40, when balloon #2 passed, and 6.87% at week 48. The FDA summary has no data beyond 48 weeks.

Side Effects Comparison
Every medical treatment has potential side effects. Here’s how the Allurion Balloon compares to GLP-1 medications:
Allurion Balloon Side Effects
- Nausea and vomiting are nearly universal in the first days as the body adjusts to the balloon, and they can recur
- Cramping or abdominal discomfort in the initial adjustment period
- Feeling of fullness (which is actually part of how the balloon works)
- Most of these symptoms resolve after the first days. In the FDA trial, 8 of 264 patients (3.0%) had device-related serious adverse events, all after balloon #2, including one gastric perforation with necrosis. The FDA summary lists death among potential adverse effects; no patient died in the trial.
- Medication can be prescribed to manage initial nausea
GLP-1 Medication Side Effects
- Nausea (reported by 44% of patients taking Wegovy in its FDA label trials)
- Vomiting and diarrhea (common, especially during dose increases)
- Constipation
- Abdominal pain
- Headache and fatigue
- Potential serious risks: pancreatitis, gallbladder disease, thyroid tumors (rare but documented in animal studies with semaglutide, carrying a boxed warning)
- Muscle loss: Some patients experience significant lean muscle mass loss alongside fat loss
- Side effects may persist for the entire duration of treatment (which is indefinite)
Allurion’s common side effects usually ease after the first days but can recur while the balloon is in place, and serious events can happen. GLP-1 side effects can be ongoing for as long as you take the medication, which may be years or even a lifetime.
Can You Combine Allurion + GLP-1?
This has not been studied in the FDA trial, which excluded weight-loss medications within 90 days of enrollment. Ask Dr. Davtyan whether it makes sense for you.
There are two primary combination approaches:
Strategy 1: Allurion First, GLP-1 for Maintenance
A doctor may consider a GLP-1 medication after the balloon if more weight management is needed. No data here show this reduces the dose or duration of medication.
Strategy 2: Transition Off GLP-1 to Allurion
Patients on GLP-1 medications who want to stop should talk with their doctor first. Using the balloon as a bridge off a GLP-1 was not studied in the FDA trial.
Strategy 3: Allurion as a GLP-1 Alternative
For patients who haven’t started GLP-1 therapy, the Allurion Balloon is a different option that avoids weekly injections. Average weight loss in GLP-1 label trials was greater; the trials are not directly comparable. Dr. Davtyan can help you evaluate whether the balloon alone may be sufficient for your goals.
At LapBandLA, we take a personalized approach. Dr. Davtyan evaluates each patient’s health profile, weight loss goals, medical history, and lifestyle to determine the optimal strategy. Explore all available medical weight loss options at our practice.
Which Is Right for You?
Deciding between the Allurion Balloon and GLP-1 medications is a personal choice that depends on your circumstances. Here’s a decision framework to help:
Choose the Allurion Balloon If:
- You want a treatment with no ongoing medication
- You prefer to avoid weekly injections indefinitely
- Long-term cost is a concern (compare $4,000 for the program with your own GLP-1 price and how long you expect to take it)
- You understand the FDA label describes short-term limited weight loss
- You value no surgery, no endoscopy, no anesthesia
- You want a comprehensive support program (coaching, tracking tools, app)
- You have a BMI of 30-40 and are between ages 22-65
Choose GLP-1 Medications If:
- You need or prefer a pharmacological approach to appetite management
- You have Type 2 diabetes and want a medication that also manages blood sugar (e.g., Ozempic)
- You are comfortable with weekly self-injections for an extended period
- You have insurance coverage that makes the medication affordable long-term
- Your doctor recommends GLP-1 therapy for specific clinical reasons
- You have a BMI above 40 and need options beyond the Allurion’s approved range
Consider Combining Both If:
- Your doctor recommends medication after the balloon
- You and your doctor are planning a change in GLP-1 treatment
- You’ve had incomplete results with one approach alone
Schedule Your Free Allurion Balloon Consultation
The best way to determine which approach is right for you is a one-on-one consultation with a weight loss specialist. Call 844-41-BALLOON to schedule your free appointment with Dr. Davtyan at any of our locations: Beverly Hills, Glendale, Rancho Cucamonga, Fountain Valley, or Marina Del Rey.
Frequently Asked Questions
Is the Allurion Balloon better than Ozempic for weight loss?
It depends on your individual goals, health profile, and preferences. The Allurion Balloon is a non-surgical treatment with no ongoing medication, while Ozempic requires weekly injections for as long as you want to maintain results. The Allurion is $4,000, and GLP-1s cost about $149 to $449 a month through manufacturer self-pay programs in 2026, depending on the product and dose; insurance varies. Average weight loss in GLP-1 label trials was greater; the trials are not directly comparable.
What happens when you stop taking Ozempic or Wegovy?
Research shows that patients who discontinue GLP-1 medications like Ozempic or Wegovy may regain up to two-thirds of their lost weight within a year of stopping treatment. This occurs because the medication’s appetite-suppressing effect ends when the drug is discontinued. The Allurion Balloon program focuses on building lifestyle habits during treatment. In the FDA trial, the 48-week result was measured about 8 weeks after balloon #2 passed. The FDA summary has no data beyond 48 weeks.
Can I use the Allurion Balloon and GLP-1 medications together?
Ask your doctor. This was not studied in the FDA trial, which excluded weight-loss medications within 90 days of enrollment. Dr. Davtyan can review both options with you.
How much does the Allurion Balloon cost compared to Ozempic?
The Allurion Balloon is $4,000 at LapBandLA. The FDA-labeled program can include up to two balloons over 10 months; ask what your quote covers. GLP-1 medications like Ozempic and Wegovy cost about $149 to $449 a month through manufacturer self-pay programs in 2026, depending on the product and dose; insurance varies, and they require ongoing use to maintain results.
Does the Allurion Balloon have fewer side effects than Ozempic?
Nausea and vomiting are nearly universal in the first days, and can recur. Cramping and fullness are also common. In the FDA trial, 8 of 264 patients (3.0%) had device-related serious adverse events, all after balloon #2, including one gastric perforation with necrosis. The FDA summary lists death among potential adverse effects; no patient died in the trial. GLP-1 medications can cause ongoing gastrointestinal side effects — including nausea, vomiting, diarrhea, and constipation — for as long as you take the medication. GLP-1s also carry rare but serious risks including pancreatitis and gallbladder problems.
Is the Allurion Balloon a good alternative to Ozempic?
It can be an option for patients who want to avoid weekly injections. Average weight loss in GLP-1 label trials was greater; the trials are not directly comparable. In its FDA trial: 6.87% average total body weight loss at 48 weeks vs 3.09% with lifestyle therapy alone, with up to two balloons. Each placement is an office visit of about 15 minutes with no surgery, no endoscopy, and no anesthesia. The coaching program and digital tools are meant to help patients build habits.





